At Genaphora, we develop a proprietary technology
for advanced molecular diagnostics kits, dramatically improving assay efficiency and accuracy, by lowering diagnostic cycles from days to hours, with the highest sensitivity and cost-effectiveness.

All of our kits employ the company's already tested and scientifically proofed unique computational-biology and primer-design methodology platforms.

Strategic partnerships with Mekorot, Israel's national water company, via WaTech from which we secured a two-year investment for $300,000 and a national water testing plan.

Patents were filed with a PCT application
covering the company's invention of novel primers design in July 2008.